189 related articles for article (PubMed ID: 20850259)
1. Organizational factors associated with the use of contingency management in publicly funded substance abuse treatment centers.
Bride BE; Abraham AJ; Roman PM
J Subst Abuse Treat; 2011 Jan; 40(1):87-94. PubMed ID: 20850259
[TBL] [Abstract][Full Text] [Related]
2. Science-based and practice-based innovativeness and performance of substance abuse treatment facilities.
Nayar P; Yu F; Apenteng B
Health Care Manage Rev; 2014; 39(1):66-74. PubMed ID: 23358133
[TBL] [Abstract][Full Text] [Related]
3. A multilevel approach to predicting community addiction treatment attitudes about contingency management.
Hartzler B; Donovan DM; Tillotson CJ; Mongoue-Tchokote S; Doyle SR; McCarty D
J Subst Abuse Treat; 2012 Mar; 42(2):213-21. PubMed ID: 22138199
[TBL] [Abstract][Full Text] [Related]
4. Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States.
Abraham AJ; Knudsen HK; Rieckmann T; Roman PM
J Stud Alcohol Drugs; 2013 Mar; 74(2):258-65. PubMed ID: 23384373
[TBL] [Abstract][Full Text] [Related]
5. The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources.
Knudsen HK; Roman PM
J Stud Alcohol Drugs; 2014 May; 75(3):476-85. PubMed ID: 24766760
[TBL] [Abstract][Full Text] [Related]
6. Patterns of organization and management in private and public substance abuse treatment programs.
Roman PM; Ducharme LJ; Knudsen HK
J Subst Abuse Treat; 2006 Oct; 31(3):235-43. PubMed ID: 16996386
[TBL] [Abstract][Full Text] [Related]
7. Organizational determinants of outpatient substance abuse treatment duration in women.
Campbell CI; Alexander JA; Lemak CH
J Subst Abuse Treat; 2009 Jul; 37(1):64-72. PubMed ID: 19038526
[TBL] [Abstract][Full Text] [Related]
8. The use of antidepressant medications in substance abuse treatment: the public-private distinction, organizational compatibility, and the environment.
Knudsen HK; Ducharme LJ; Roman PM
J Health Soc Behav; 2007 Jun; 48(2):195-210. PubMed ID: 17583274
[TBL] [Abstract][Full Text] [Related]
9. The employment of nurses in publicly funded substance abuse treatment programs.
Knudsen HK; Abraham AJ
J Addict Nurs; 2012 Oct; 23(3):174-80. PubMed ID: 24135687
[TBL] [Abstract][Full Text] [Related]
10. Organizational and client determinants of cost in outpatient substance abuse treatment.
Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
[TBL] [Abstract][Full Text] [Related]
11. Adolescent-only substance abuse treatment: availability and adoption of components of quality.
Knudsen HK
J Subst Abuse Treat; 2009 Mar; 36(2):195-204. PubMed ID: 19000942
[TBL] [Abstract][Full Text] [Related]
12. Organizational-level predictors of adoption across time: naltrexone in private substance-use disorders treatment centers.
Oser CB; Roman PM
J Stud Alcohol Drugs; 2007 Nov; 68(6):852-61. PubMed ID: 17960303
[TBL] [Abstract][Full Text] [Related]
13. Modeling the use of innovations in private treatment organizations: the role of absorptive capacity.
Knudsen HK; Roman PM
J Subst Abuse Treat; 2004 Jan; 26(1):353-61. PubMed ID: 14698799
[TBL] [Abstract][Full Text] [Related]
14. Health services for women in outpatient substance abuse treatment.
Campbell CI; Alexander JA
Health Serv Res; 2005 Jun; 40(3):781-810. PubMed ID: 15960691
[TBL] [Abstract][Full Text] [Related]
15. Treatment programs in the National Drug Abuse Treatment Clinical Trials Network.
McCarty D; Fuller B; Kaskutas LA; Wendt WW; Nunes EV; Miller M; Forman R; Magruder KM; Arfken C; Copersino M; Floyd A; Sindelar J; Edmundson E
Drug Alcohol Depend; 2008 Jan; 92(1-3):200-7. PubMed ID: 17875368
[TBL] [Abstract][Full Text] [Related]
16. Insights from a national survey into why substance abuse treatment units add prevention and outreach services.
Wells R; Lemak CH; D'Aunno TA
Subst Abuse Treat Prev Policy; 2006 Aug; 1():21. PubMed ID: 16887037
[TBL] [Abstract][Full Text] [Related]
17. A categorical typology of naltrexone-adopting private substance abuse treatment centers.
Oser CB; Roman PM
J Subst Abuse Treat; 2008 Jun; 34(4):433-42. PubMed ID: 17997266
[TBL] [Abstract][Full Text] [Related]
18. New directions in substance abuse services: programmatic innovations in the Veterans Administration.
Peterson KA; Swindle RW; Moos RH; Finney JW; Suchinsky RT
J Ment Health Adm; 1992; 19(1):41-52. PubMed ID: 10171035
[TBL] [Abstract][Full Text] [Related]
19. Organizational- and individual-level correlates of posttreatment substance use: a multilevel analysis.
Ghose T
J Subst Abuse Treat; 2008 Mar; 34(2):249-62. PubMed ID: 17600654
[TBL] [Abstract][Full Text] [Related]
20. Do licensing and accreditation matter in outpatient substance abuse treatment programs?
Wells R; Lemak CH; Alexander JA; Nahra TA; Ye Y; Campbell CI
J Subst Abuse Treat; 2007 Jul; 33(1):43-50. PubMed ID: 17588488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
